Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Human Siglec-1/CD169 Antibody, R&D Systems™
GREENER_CHOICE

Sheep Polyclonal Antibody has been used in 2 publications

Supplier:  R&D Systems AF5197

Catalog No. AF5197


Only null left
Add to Cart
This item is not returnable. View return policy

Description

Description

Siglec-1/CD169 Polyclonal specifically detects Siglec-1/CD169 in Human samples. It is validated for Western Blot, Neutralization.
Specifications

Specifications

Siglec-1/CD169
Polyclonal
Unconjugated
Q9BZZ2
SIGLEC1
Mouse myeloma cell line NS0-derived recombinant human Siglec-1/CD169 Ser20-Gln1641 Accession # Q9BZZ2
100 μg
Primary
Detects human Siglec-1/CD169 in direct ELISAs and Western blots. In direct ELISAs, approximately 20% cross-reactivity with recombinant mouse Siglec-1 is observed and less than 1% cross-reactivity with recombinant human Siglec-2 is observed.
Human
IgG
Western Blot, Neutralization
LYOPH
Western Blot 0.5 ug/mL, Neutralization 1.5-7.5 ug/mL
CD169, FLJ00051, sialic acid binding Ig-like lectin 1, sialoadhesin, sialoadhesin, Siglec1
Sheep
Affinity Purified
RUO
6614
Reconstitute at 0.2 mg/mL in sterile PBS.
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.